Price T Rowe Associates Inc Prothena Corp Public LTD CO Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,822,434 shares of PRTA stock, worth $53.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,822,434

Previous 4,237,404 9.79%

Holding current value

$53.7 Million

Previous $87.5 Million 26.88%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.73 - $24.79 $6.94 Million - $10.3 Million	-414,970 Reduced 9.79%	3,822,434 $64 Million
Q2 2024 Aug 14, 2024	BUY	$19.54 - $26.15 $696,268 - $931,802	35,633 Added 0.85%	4,237,404 $87.5 Million
Q1 2024 May 15, 2024	SELL	$24.75 - $40.66 $880,605 - $1.45 Million	-35,580 Reduced 0.84%	4,201,771 $104 Million
Q4 2023 Feb 14, 2024	BUY	$32.31 - $52.32 $13.5 Million - $21.8 Million	417,338 Added 10.93%	4,237,351 $154 Million
Q3 2023 Nov 14, 2023	BUY	$47.3 - $70.6 $12.6 Million - $18.8 Million	266,245 Added 7.49%	3,820,013 $184 Million
Q2 2023 Aug 14, 2023	BUY	$48.26 - $78.59 $17 Million - $27.6 Million	351,475 Added 10.98%	3,553,768 $243 Million
Q1 2023 May 15, 2023	SELL	$46.97 - $58.27 $169,561 - $210,354	-3,610 Reduced 0.11%	3,202,293 $155 Million
Q4 2022 Feb 14, 2023	BUY	$52.05 - $65.0 $11.7 Million - $14.6 Million	223,962 Added 7.51%	3,205,903 $193 Million
Q3 2022 Nov 14, 2022	SELL	$25.16 - $60.63 $75.1 Million - $181 Million	-2,983,847 Reduced 50.02%	2,981,941 $181 Million
Q2 2022 Aug 15, 2022	SELL	$22.73 - $39.98 $3.36 Million - $5.92 Million	-147,954 Reduced 2.42%	5,965,788 $162 Million
Q1 2022 May 16, 2022	BUY	$30.27 - $49.22 $4.99 Million - $8.12 Million	164,881 Added 2.77%	6,113,742 $224 Million
Q4 2021 Feb 14, 2022	SELL	$42.11 - $73.26 $4.79 Million - $8.33 Million	-113,768 Reduced 1.88%	5,948,861 $294 Million
Q3 2021 Nov 15, 2021	BUY	$48.2 - $78.89 $11.5 Million - $18.9 Million	239,544 Added 4.11%	6,062,629 $432 Million
Q2 2021 Aug 16, 2021	BUY	$21.63 - $57.65 $54.3 Million - $145 Million	2,510,739 Added 75.8%	5,823,085 $299 Million
Q1 2021 May 17, 2021	BUY	$11.0 - $28.24 $36.3 Million - $93.1 Million	3,297,931 Added 22878.47%	3,312,346 $83.2 Million
Q4 2020 Feb 16, 2021	BUY	$10.12 - $13.94 $145,879 - $200,945	14,415 New	14,415 $173,000

Others Institutions Holding PRTA

# of Institutions

184

Shares Held

42.7M

Call Options Held

162K

Put Options Held

102K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $659M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Prothena Corp Public LTD CO Transaction History